[144] Stoke Therapeutics, Inc. SEC Filing

Rhea-AI Filing Summary

Stoke Therapeutics (STOK) filed a Rule 144 notice for a proposed sale of 25,000 common shares acquired by an exercise of stock options on 10/08/2025. The shares are to be sold through Morgan Stanley Smith Barney LLC with an aggregate market value of $682,750 against 54,797,418 shares outstanding, indicating the block is a very small portion of the float. The filing shows the option exercise and cash payment both occurred on 10/08/2025, and the seller certifies no undisclosed material nonpublic information.

Related trading history lists 116,472 shares sold in the past three months by the same named insider, generating gross proceeds of $2,532,056.28, executed under a mix of 10b5-1 program and direct sales. These prior disposals and the new Rule 144 notice document routine insider liquidity rather than company operational changes.

Positive

• Exercise funded in cash on 10/08/2025, indicating no seller-side financing
• Brokered through a major firm (Morgan Stanley Smith Barney LLC), supporting orderly execution
• Size is immaterial to float: 25,000 shares is ~0.046 of 54,797,418 outstanding

Negative

• Insider selling activity totaled 116,472 shares in the past three months, raising liquidity questions
• Aggregate insider proceeds of $2,532,056.28 over three months could be perceived negatively by some investors

Insights

Equity Transactions Analyst

TL;DR: Insider exercised options and is selling a small block; recent 3‑month insider sales total $2.53M.

The transaction shows a 10/08/2025 option exercise for 25,000 shares paid in cash and routed to market via Morgan Stanley Smith Barney LLC. The sale size equals 0.046 of outstanding shares, so direct dilution or market impact is likely minimal.

Recent filings show 116,472 shares sold over three months for $2,532,056.28, many executed under a 10b5-1 plan. Watch for additional scheduled 10b5-1 trades or further Form 144 filings over the next 30–90 days as the best near-term indicator of insider liquidity strategy.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	25000	682750.00	54797418	10/08/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/08/2025	Exercise of Stock Options	Issuer			25000	10/08/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for EDWARD KAYE 45 Wiggins Ave Bedford MA 01730	Common	10/03/2025	42461	1065204.61
10b5-1 Sales for EDWARD KAYE 45 Wiggins Ave Bedford MA 01730	Common	09/03/2025	45996	925858.08
10b5-1 Sales for EDWARD KAYE 45 Wiggins Ave Bedford MA 01730	Common	09/02/2025	14860	299259.60
10b5-1 Sales for EDWARD KAYE 45 Wiggins Ave Bedford MA 01730	Common	08/29/2025	1029	20580.00
EDWARD M KAYE 45 Wiggins Ave Bedford MA 01730	Common	08/18/2025	12126	221153.99

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed by STOK disclose about the proposed sale?

It discloses a proposed sale of 25,000 common shares acquired by option exercise on 10/08/2025 with an aggregate market value of $682,750.

Who is handling the sale of the shares in the Form 144 for STOK?

The sale is to be placed through Morgan Stanley Smith Barney LLC at their New York address as listed in the filing.

How many shares has the insider sold in the past three months according to the filing?

The filing lists 116,472 shares sold in the past three months, generating gross proceeds of $2,532,056.28.

How were the 25,000 shares acquired according to the filing?

They were acquired by exercise of stock options on 10/08/2025, and payment was made in cash on the acquisition date.

Does the filing state whether the seller has any material nonpublic information?

By signing the notice, the seller represents they do not know any material adverse nonpublic information about the issuer.

Are prior sales noted as 10b5-1 transactions in the filing?

Yes; several prior sales in the past three months are identified as 10b5-1 sales for the named insider.